Distribution of Maternal High-Risk Factors Across Amniotic Fluid Volume Categories in High-Risk Pregnancies

Main Article Content

Kanwal Bano
Dr Maaz Khan
Attiqa Raqeeb
Aneeza Eman
Aimen Saeed
Mehwish Kalsoom

Abstract

Background: Amniotic fluid volume abnormalities are common in high-risk pregnancies and reflect underlying maternal and fetal conditions, yet the distribution of specific maternal risk factors across different amniotic fluid categories remains insufficiently characterized. Objective: To evaluate the frequency and distribution of maternal high-risk factors across normal amniotic fluid volume, oligohydramnios, and polyhydramnios in high-risk pregnancies. Methods: This cross-sectional observational study included 81 high-risk pregnant women at ≥28 weeks gestation. Amniotic fluid volume was assessed using the amniotic fluid index and categorized as normal (5–25 cm), oligohydramnios (<5 cm), or polyhydramnios (>25 cm). Maternal risk factors, including hypertension, diabetes mellitus, preeclampsia, obstetric history, intrauterine growth restriction, and congenital anomalies, were recorded. Associations were analyzed using chi-square tests and odds ratios with 95% confidence intervals. Results: Normal amniotic fluid volume was observed in 60.5% of cases, oligohydramnios in 19.8%, and polyhydramnios in 19.8%. Intrauterine growth restriction was significantly associated with oligohydramnios (31.2% vs 8.2%; OR 5.13, p=0.02), while diabetes mellitus was strongly associated with polyhydramnios (37.5% vs 10.2%; OR 5.28, p=0.02). Hypertension and preeclampsia showed higher prevalence in oligohydramnios but were not statistically significant. The presence of ≥2 risk factors was associated with a threefold increase in abnormal amniotic fluid volume (OR 3.24, p=0.03). Conclusion: Maternal high-risk factors exhibit distinct distribution patterns across amniotic fluid categories, with oligohydramnios linked to placental insufficiency-related conditions and polyhydramnios associated with metabolic and structural factors. These patterns support targeted clinical evaluation and improved risk stratification.

Article Details

Section

Articles

How to Cite

1.
Kanwal Bano, Dr Maaz Khan, Attiqa Raqeeb, Aneeza Eman, Aimen Saeed, Mehwish Kalsoom. Distribution of Maternal High-Risk Factors Across Amniotic Fluid Volume Categories in High-Risk Pregnancies. JHWCR [Internet]. 2026 Apr. 15 [cited 2026 Apr. 24];4(7):1-9. Available from: https://jhwcr.com/index.php/jhwcr/article/view/1477

References

1. Alscreen M, et al. Amniotic fluid physiology. Obstet Gynecol Clin North Am. 2019;46(2):227–240.

2. Crellin HB, Singh V. Sonography evaluation of amniotic fluid. StatPearls. 2025.

3. Yeung YK, et al. Longitudinal fetal growth parameters. Ultrasound Obstet Gynecol. 2025;66(3):314–323.

4. ACOG Committee Opinion. Indications for outpatient antenatal fetal surveillance. Obstet Gynecol. 2021;137(6):e177–197.

5. Mandal A, et al. IUGR and perinatal outcome in oligohydramnios. Asian J Med Sci. 2022;13(8):186–194.

6. Hassan T ul, et al. Association of preeclampsia with oligohydramnios. J Mod Health Rehabil Sci. 2024;1:1–5.

7. Horcas-Martín M, et al. Polyhydramnios at term in gestational diabetes. Children. 2025;12(7).

8. Bakhsh H, et al. Amniotic fluid disorders and prenatal outcome. BMC Pregnancy Childbirth. 2021;21(1).

9. Akthar S, et al. Impact of low AFI at term on perinatal outcome. Int J Clin Obstet Gynaecol. 2024;110(3):110–114.

10. Liu Y, et al. Prenatal diagnosis of chromosomal aberrations in polyhydramnios. J Matern Fetal Neonatal Med. 2024;37(1):2344089.

11. Jha P, et al. Assessment of amniotic fluid volume in pregnancy. Radiographics. 2023;43(6).

12. Sgayer I, et al. Borderline amniotic fluid levels and adverse outcome. Ultrasound Obstet Gynecol. 2025;66(5):562–570.

13. Blitz MJ, et al. Maternal BMI and amniotic fluid index. J Ultrasound Med. 2018;37(3):561–568.

14. Dammer U, et al. Perinatal outcome with isolated oligohydramnios. In Vivo. 2024;38(2):754.

15. Molla M, et al. Adverse perinatal outcomes with oligohydramnios. Front Glob Womens Health. 2022;3:958617.

16. Fatema J, et al. Oligohydramnios and maternal/neonatal outcomes.

17. Kechagias KS, et al. Outcomes in idiopathic polyhydramnios. Sci Rep. 2024;14(1):5296.

18. Pagan M, et al. Idiopathic polyhydramnios and pregnancy outcome. Ultrasound Obstet Gynecol. 2023;61(3):302–309.

19. Weerakkody Y, Knipe H. Hydrops fetalis. Radiopaedia.org. 2010.

20. Gao H, et al. Pregnancy outcomes in idiopathic oligohydramnios. Int J Womens Health. 2025;17:1665–1672.

21. Whittington JR, et al. Amniotic fluid and postnatal outcomes. Int J Womens Health. 2023;15:117–124.

22. Yamaji N, et al. Tocolytic therapy in high-risk populations. Children. 2023;10(3):443.